Brazil Market Report for Dental Implant Fixtures 2017 - MedCore
Dental implant fixtures are artificial tooth roots that support a restoration placed for a missing tooth or teeth and aid in the prevention of jaw bone loss. They are typically offered in the form of a metal-based material such as titanium and are inserted into the jaw to replace missing teeth. They can be described based on their shape and method of attachment to the jaw. In the case that a patient suffers tooth loss from tooth decay, root canal failure, gum disease (periodontists), trauma to the mouth (a tooth injury), excessive wear and tear or congenital defects, he or she may be in the position to receive an implant fixture. Other options are available on the market in the case that a patient has a missing tooth. Experts now regard implant fixtures with attached crowns as the preferred method for treating tooth loss because implants maintain the same functionalities as natural teeth and help preserve the jaw structure by preventing atrophy from bone loss. Bridgework and dentures are an alternative solution that addresses the cosmetic issue of having a missing tooth, but they do not prevent bone loss. Permanent implants maintain proper chewing function and exert appropriate, natural forces on the jawbone to keep it functional and healthy.
General Report Contents
Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
Market Drivers & Limiters for each chapter segment
Competitive Analysis for each chapter segment
Section on recent mergers & acquisitions
Dental implant fixture sales will gradually expand throughout the forecast period, mimicking growth of the slowly recovering economy. Additionally, improved education and awareness will help more individuals realize that an implant fixture is not just an avoidable cost, thereby reducing the incidences of delay in receiving a dental implant. This trend further facilitates the continual growth of implant fixture sales, which will reach just under 4.2 million units by 2023. It is important to note that these market estimates are inclusive of imitation brands, which refer to illegal sales that claim bioequivalence to premium products at a much cheaper price point. Known as off-label sales or copy-cat companies, these appeal to the wider public as premium products are typically beyond the budget of most consumers.